SAMN03167022
External Id
dbGaP
INSDC center name
2014-11-07T00:24:51.937Z
INSDC first public
2024-05-07T10:12:37.890Z
INSDC last update
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
ERS19681430
SRA accession
RNA
analyte type
NCI_AdjuvantTrastuzumab_NSABP_B31
biospecimen repository
1196
biospecimen repository sample id
breast
http://purl.obolibrary.org/obo/UBERON_0000310
body site
phs000826
gap_accession
1
gap_consent_code
DS-CA-IRB-MDS
gap_consent_short_name
1425092
gap_sample_id
1092299
gap_subject_id
Ductal Adenocarcinoma
histological type
Yes
is tumor
miRNA Expression (Array)
molecular data type
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
Clinical Trial
study design
Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31
study name
1196
submitted sample id
1196
submitted subject id
NCI_AdjuvantTrastuzumab_NSABP_B31
submitter handle
Tumor RNA sample from breast of a human participant in the dbGaP study Prediction of Trastuzumab Benefit in Adjuvant Breast Cancer: NSABP B31
title